GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats
- PMID: 11806463
GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats
Abstract
GLP-1 (glucagon-like peptide 1), proposed as a possible tool for Type 2 diabetes therapy, has insulin-like effects upon glucose metabolism in extrapancreatic tissues, whose plasma membranes contain specific receptors for the peptide, being those, at least in liver and muscle, not associated to the adenylate cyclase/cAMP system. GLP-1, as insulin, modulates the content of glycosylphosphatidylinositols (GPIs)--precursors of inositolphosphoglycans (IPGs), considered mediators of insulin action--in several extrapancreatic cell lines and in normal rat hepatocytes and adipocytes. In the present paper, we document that in a streptozotocin-induced Type 2 diabetic rat model, GLP-1, as insulin, provokes a rapid decrease of the [myo-3H-inositol]GPI content in isolated adipocytes--indicative of its hydrolysis and immediate short-lived generation of IPG--as that previously observed in normal animals; in hepatocytes, GLP-1, but not insulin, induced a reduction in the cellular GPI, although delayed in relation to normal rats. In adipocytes from streptozotocin-induced Type 1 diabetic rats, GLP-1, as insulin, seems to induce a reduction in the cellular GPI content, which was smaller and occurred later than that provoked in the Type 2 diabetic model; in the hepatocytes, GLP-1 and insulin failed to affect the control GPI content at any time tested. In Type 2 diabetic rat, the hepatocyte retains its response capability to GLP-1, but not to insulin, suggesting that the peptide could be bypassing possible defective steps in the insulin signaling pathway in the liver of this diabetic model.
Similar articles
-
Inositolphosphoglycans possibly mediate the effects of glucagon-like peptide-1(7-36)amide on rat liver and adipose tissue.Cell Biochem Funct. 1998 Mar;16(1):51-6. doi: 10.1002/(SICI)1099-0844(199803)16:1<51::AID-CBF767>3.0.CO;2-T. Cell Biochem Funct. 1998. PMID: 9580153
-
Inositolphosphoglycans and diacyglycerol are possible mediators in the glycogenic effect of GLP-1(7-36)amide in BC3H-1 myocytes.Cell Biochem Funct. 1996 Mar;14(1):43-8. doi: 10.1002/cbf.639. Cell Biochem Funct. 1996. PMID: 8907253
-
Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.Horm Metab Res. 2004 Nov-Dec;36(11-12):852-8. doi: 10.1055/s-2004-826175. Horm Metab Res. 2004. PMID: 15655719 Review.
-
Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.Regul Pept. 2005 Jun 15;128(2):149-57. doi: 10.1016/j.regpep.2004.06.003. Regul Pept. 2005. PMID: 15780434 Review.
-
Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).Mol Genet Metab. 2001 Jul;73(3):248-58. doi: 10.1006/mgme.2001.3186. Mol Genet Metab. 2001. PMID: 11461192
Cited by
-
Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes.Br J Pharmacol. 2016 Jun;173(11):1820-34. doi: 10.1111/bph.13481. Epub 2016 Apr 28. Br J Pharmacol. 2016. PMID: 26993859 Free PMC article.